Codice QR

Lessons from a National Liquid Biopsy Program to Provide Cancer Testing and Treatment for Patients with Advanced Solid Tumors

Personalized cancer treatment depends on the accurate and timely detection of the patient tumor variants. LBx enables minimally invasive tumor mutation profiling. We report results of a pan-Canadian LBx program for patients with advanced solid tumors. Plasma samples were tested at Imagia Canexia Hea...

Descrizione completa

Salvato in:
Autori principali: Anna Lapuk, Benjamin L. S. Furman, Pedro Feijao, Ebru Baran, Sonal Brahmbhatt, Betty Chan, Ka Mun Nip, Adrian Kense, Brenda Murphy, Ruth Miller, Vincent Funari, Alicja Parker, Melissa K. McConechy, Shaqil Kassam, Arif A. Awan, Bryan Lo, Daniel Breadner, Barry D. Stein, David G. Huntsman
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2025-12-01
Serie:Current Oncology
Soggetti:
liquid biopsy
NGS
biomarkers
precision oncology
health economics
Accesso online:https://www.mdpi.com/1718-7729/33/1/18
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi